nitrofurantoin has been researched along with carbapenems in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Duff, P | 1 |
Kamiya, S; Taguchi, H | 1 |
Bachmann, A; Bonkat, G; Braissant, O; Frei, R; Gasser, TC; Müller, G; Rieken, M; Tschudin-Suter, S; Widmer, AF; Wyler, S | 1 |
Alfandari, S; Bajolet, O; Blanchard, H; Colomb-Cotinat, M; Daniau, C; Dumartin, C; Lecuru, M; Simon, L | 1 |
2 review(s) available for nitrofurantoin and carbapenems
Article | Year |
---|---|
Antibiotic selection in obstetrics: making cost-effective choices.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Carbapenems; Cephalosporins; Clindamycin; Cost-Benefit Analysis; Female; Fluoroquinolones; Humans; Linezolid; Metronidazole; Nitrofurantoin; Oxazolidinones; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Trimethoprim, Sulfamethoxazole Drug Combination | 2002 |
[Prospect of the development of new bactericidal drugs against Helicobacter pylori for eradication therapy].
Topics: Animals; Anti-Bacterial Agents; Benzenesulfonates; Carbapenems; Cetylpyridinium; Drug Design; Drug Resistance, Bacterial; Ellagic Acid; Fish Oils; Food Analysis; Glycyrrhizic Acid; Helicobacter Infections; Helicobacter pylori; Nitrofurantoin; Rifamycins; Thiazoles | 2002 |
2 other study(ies) available for nitrofurantoin and carbapenems
Article | Year |
---|---|
Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ciprofloxacin; Contraindications; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Male; Middle Aged; Nitrofurantoin; Prevalence; Retrospective Studies; Treatment Failure; Treatment Outcome; Urinary Tract; Urinary Tract Infections; Young Adult | 2013 |
Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France.
Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Cross Infection; Delivery of Health Care; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Nitrofurantoin; Ofloxacin; Penicillins; Urinary Tract Infections | 2022 |